Oxaliplatin-associated neuropathy: a blood marker unrelated to symptoms in an exploratory study
In 30 patients receiving chemotherapy, blood pNF-H was not associated with the onset, severity or persistence of neuropathy.
Read the newsThe news feed
Recent studies and announcements, explained with the same rigor as our analyses: sources, context, and the limitations of the data.
The publication feed
ADHD in children: promising digital interventions, but varying effects
A meta-analysis of 37 randomized trials suggests benefits for symptoms and cognition, without establishing their practical magnitude.
MRI and cognition: markers associated with cognitive impairment in small vessel disease
A review of 15 studies links white matter abnormalities to poorer cognitive performance, without establishing their reliability for early screening.
Anesthesia and back surgery: a planned trial on cerebral oxygenation in older patients
A protocol plans to compare remimazolam with propofol during spine surgery in the prone position. No results have been reported yet.
Neuropathic pain: exosomes remain a largely preclinical research avenue
A systematic review brings together 17 studies on stem cell-derived exosomes. The findings are largely preclinical and do not demonstrate efficacy in humans.
Dementia in care facilities: virtual reality performs no better than cognitive stimulation in a trial
A trial involving 56 residents shows no greater benefit from virtual reality for behavioral symptoms or well-being.
MicroRNAs and neurological diseases: a promising review, but exclusively preclinical
A review of 37 studies explores microRNAs derived from mesenchymal stem cells in Parkinson’s, Alzheimer’s and stroke. No benefit in humans has been established.
Digital cognitive training: potential lasting benefits in older adults with mild impairment
A trial suggests sustained benefits after 20 hours of digital cognitive training, but their magnitude and the advantage over games remain unclear.